Hepatitis C in Developing Countries

Professor Sanaa Kamal works at the Department of Gastroenterology and Hepatology within in the Ain Shams Faculuty of Medicine. She is a leading authority on the treatment and stidy of hepatitis C.

1. Global Burden of Hepatitis C Section 1.1 The Public Health and Health Care Burden of Hepatitis C Infection Section 1.2 The Economic Burden of Hepatitis C Infection Section 1.3 The Social Burden of Hepatitis C Infection

2. The Epidemic of Hepatitis C in Developing Countries Section 2.1 HCV Statistics in Developing Countries Section 2.2 The Growing Challenge of Hepatitis C in Developing Countries Subsection 2.2.a  Epidemiology of Hepatitis C in Developing Countries Subsection 2.2.b  Modes of Transmission of Hepatitis C in Developing Countries Subsection 2.2 c  Socio-political Aspects of Hepatitis C in Developing Countries Subsection 2.2.d. Hepatitis C Genotypes in Developing Countries Subsection 2.2 e. Clinical Patterns and Complications of Hepatitis C Infection in Developing Countries Subsection 2.2.e  Access to Hepatitis C Treatment in Developing Countries Subsection 2.2.f. Impact of Coinfections on Hepatitis C in Developing Countries Section 2.3  Macro and Micro-economics of Hepatitis C in Developing Countries

3. The Magnitude of Hepatitis C Problem in Specific Regions Section 3.1 Hepatitis C in Egypt Section 3.2  Hepatitis C in Africa Section 3.3  Hepatitis C in the Middle East Section 3.1 Hepatitis C in Indian Subcontinent Section 3.2  Hepatitis C in Latin America Section 3.3  Hepatitis C in Southeast Asia

4. Challenges of Hepatitis C in Developing Countries Section 4.1 Direct Acting Antiviral Agents in Developing Countries Section 4.2 Challenges of Producing Drugs and Potential Vaccines for Hepatitis C Specifically for Developing Countries Section 4.3 Ethics of Hepatitis C Clinical Trials and Research in Developing Countries Section 4.4 Applications of Genetics in Developing Countries Section 4.5 Hepatitis C Surveillance and Prevention in Developing Countries